Search

USPTO Patent Grant for Peptides Treating Type 1 Diabetes

The USPTO has granted patent US12583891B2 to PHOENIX ALPHA for peptides and methods used in the treatment of type 1 diabetes. The patent covers specific peptide sequences and their application in generating cytolytic CD4+ T cells.

USPTO Patent Granted for Dissociative Disorder Treatment Methods

The USPTO has granted a patent (US12582616B2) to The Board of Trustees of the Leland Stanford Junior University for methods of treating dissociative disorders. The patent covers agents that modulate neural activity in the posteromedial cortex to treat these conditions.

Bifunctional compounds for degrading BTK via ubiquitin pathway

The USPTO has granted patent US12582722B2 to Nurix Therapeutics, Inc. for bifunctional compounds designed to degrade Bruton's tyrosine kinase (BTK) through the ubiquitin proteolytic pathway. The patent covers novel compounds and pharmaceutical compositions for treating various diseases.

USPTO Patent Grant: Theranostic Agents for PSMA Positive Cancers

The USPTO has granted a patent (US12582728B2) to Memorial Sloan Kettering Cancer Center for theranostic agents targeting PSMA positive cancers. The patent covers compositions and methods for detecting and treating cancer using novel radiohalogenated PSMA targeting agents for diagnostic imaging and radiation therapy.

USPTO Patent Grant: Kit for Producing and Storing Radiopharmaceuticals

The USPTO has granted patent US12582729B2 to Wake Forest University Health Sciences for a kit technology designed for the production and long-term storage of Zr-89-PET radiopharmaceuticals. The patent covers improved stability for radiopharmaceuticals and a method for their production.

Patent: ROS-detonable Nanoclusters for Anti-Restenotic Therapy

The USPTO has granted a patent (US12582613B2) for biomimetic, reactive oxygen species-detonable nanoclusters designed for anti-restenotic therapy. The technology, assigned to the University of Virginia Patent Foundation, involves nanoclusters with self-assembled cores and biomimetic membrane coatings that can deliver anti-restenotic drugs.

USPTO Grants Patent for ACE Inhibitor and Blood Pressure-Lowering Agent

The USPTO has granted a patent (US12582146B2) to MARUZEN PHARMACEUTICALS CO., LTD. for an angiotensin-converting enzyme inhibitor and blood pressure-lowering agent containing a specific compound. The patent also covers beverages and food products incorporating this compound.

USPTO Grants Patent for Bis-biguanide Compounds in Cancer Management

The USPTO has granted a patent (US12582618B2) to Emory University for bis-biguanide compounds and pharmaceutical compositions for managing cancer, particularly lung cancer. The patent covers methods of treatment and related compositions, with an effective grant date of March 24, 2026.

Moderna Cancer Vaccines Patent Grant

The USPTO has granted patent US12582609B2 to ModernaTX, Inc. for cancer ribonucleic acid (RNA) vaccines. The patent covers cancer RNA vaccines, methods of use, and compositions. This grant is a routine notification of intellectual property protection.

USPTO Patent Grant: B-RAF Kinase Inhibitor Solid Dispersion

The USPTO has granted a patent to BeiGene, Ltd. for a stable solid dispersion of a B-RAF kinase dimer inhibitor, Compound 1. The patent covers the composition, methods of preparation, and uses of this solid dispersion, as well as a crystalline form of Compound 1.

USPTO Patent Grant: Topical Anti-inflammatory Composition with Zileuton

The USPTO has granted a patent (US12582598B2) to QURIENT CO., LTD. for a topical anti-inflammatory pharmaceutical composition comprising Zileuton. The patent covers the composition, its uses, and methods of preparation.

Andrew Merdinyan License Emergency Suspension Order

The New Hampshire Board of Pharmacy has issued an emergency suspension order for the license of Andrew Merdinyan, a Registered Pharmacy Technician. The suspension is due to findings of probable cause that the licensee engaged in conduct posing an imminent danger to public health, safety, and welfare, including admitting to taking controlled medications from a pharmacy.

Walmart Pharmacy Disciplinary Final Order

The New Hampshire Board of Pharmacy issued a disciplinary final order against Walmart Pharmacy concerning multiple locations. The order details the procedures and timelines for filing petitions for rehearing and the right to appeal the decision to the New Hampshire Supreme Court.

Felicia Dern - Voluntary Surrender of Pharmacy Tech License

The New Hampshire Board of Pharmacy has accepted the voluntary surrender of Felicia Dern's Registered Pharmacy Technician license (PHT-130661). This action follows allegations of drug diversion and substance misuse disorder, which led to her termination from Rite Aid.

NH Board of Pharmacy - Emergency Suspension of Pharmacist License

The New Hampshire Board of Pharmacy has issued an emergency order suspending the license of pharmacist Justin Eric Lachance. The suspension follows findings of suspected diversion of controlled substances, including Clonazepam and Zolpidem, observed via Walgreens surveillance and confessed by the licensee.

Andrew Merdinyan - Pharmacy Technician License Surrender

The New Hampshire Board of Pharmacy has accepted the voluntary surrender of Andrew Merdinyan's pharmacy technician license (PhT-131188) due to allegations of controlled drug diversion. Merdinyan allegedly diverted approximately 1,236 tablets/capsules from a Walgreens pharmacy.

Georgia Pharmacy Board Actions - January 2026

The Georgia Board of Pharmacy has issued its January 2026 Public Board Actions List. This list details enforcement actions taken against licensees, including the summary suspension of a facility's license and the lifting of a pharmacist's suspension. Specific licensee names and license numbers are provided for each action.

Georgia Pharmacy Board Actions - February 2026

The Georgia Board of Pharmacy has issued a list of actions taken in February 2026. These actions include a voluntary surrender for a technician and a consent order for a facility, Xttrium Laboratories, Inc. Specific details on the nature of the consent order and surrender are pending further documentation.

GA Board of Pharmacy Actions - January 2025

The Georgia Board of Pharmacy has revoked the registration of Yental Breanna Alford (PHTC051190) in its January 2025 public actions list. This action pertains to a pharmacy technician.

GA Board of Pharmacy Actions - February 2025

The Georgia Board of Pharmacy has issued a list of actions taken in February 2025. These actions include a voluntary cease and desist order for Steri-Tek PHWH004241 and a consent order for S2 Medical Supply, LLC (PHDME000685). Specific details on the nature of violations or penalties are not provided in this summary.

Georgia Board of Pharmacy Consent Orders and Revoked Registrations

The Georgia Board of Pharmacy has issued consent orders for Musely Compounding Pharmacy East LLC and Cornerstone Medical, Inc. Additionally, registrations for technicians Amira Jayde Brooks and Cythnia Elaine Brannon have been revoked.

GOMAVU Trademark Application Published for Opposition

The USPTO has published the GOMAVU trademark application for opposition. The application, filed on September 16, 2025, covers products such as toilet deodorants and deodorizers. The publication date for opposition is March 22, 2026.

New You Pretty Energy Trademark Application

The United States Patent and Trademark Office (USPTO) has received a new trademark application for 'NEW YOU PRETTY ENERGY' filed on October 8, 2025. The application is for intent to use and covers various energy drinks, dietary supplements, and related products.

USPTO Trademark Application for Probelle

The USPTO has received an intent-to-use trademark application for the mark "Probelle" filed on October 28, 2025. The application covers goods including dietary supplements, nutritional supplements, and herbal supplements.

PINAINICE Trademark Publication

The USPTO has published the trademark application for PINAINICE, covering various medicated skin care preparations and pharmaceutical substances. The application was filed on October 29, 2025, and published for opposition on March 22, 2026.

YOYOFOX Trademark Application Published for Opposition

The USPTO has published the YOYOFOX trademark application for opposition, covering self-adhesive dressings, elastic bandages, and hydrogel for medical purposes. The application was filed on October 21, 2025, and published on March 22, 2026.

USPTO Trademark Application - Equine Products Ireland

The USPTO has received an intent-to-use trademark application from Equine Products Ireland for vitamins and dietary food supplements for animals. The application was filed on October 30, 2025.

NUMIATE Trademark Intent to Use Application

The USPTO has received an intent to use trademark application for "NUMIATE" (TM99477578) filed on November 4, 2025. The application covers medicated and non-medicated skin care preparations. This filing indicates a future intention to use the mark in commerce.

USPTO Trademark Publication: THE DAILY 4

The USPTO has published the trademark application for 'THE DAILY 4' for opposition. The application covers dietary and nutritional supplements, vitamin and mineral supplements, and online ordering services for these products. The filing date was November 4, 2025.

USPTO Trademark Application for Honest Dose Supplements

The USPTO has received an intent-to-use trademark application for 'Honest Dose' for various supplements, including probiotic, vitamin, mineral, and herbal supplements. The application was filed on November 4, 2025, with an intended use date of March 22, 2026.

Navy St. Trademark Application - Intent to Use

The USPTO has received an intent-to-use trademark application for the mark 'NAVY ST.' filed on November 11, 2025. The application covers a range of pharmaceutical and cosmetic products, including acne treatments, medicated cosmetics, sunscreens, moisturizers, and hair care products.

USPTO Trademark Application - Metabolic Hydration

The USPTO has received an intent-to-use trademark application for 'METABOLIC HYDRATION' for a powdered nutritional supplement drink mix. The application was filed on November 12, 2025, with an intended use date of March 22, 2026.

MAEVA Intent to Use Trademark Application for Supplements

The USPTO has received an intent-to-use trademark application (TM99492340) for the mark 'MAEVA'. The application covers powdered supplement drink mixes, protein powders, and other nutritional powders for human consumption. The filing date for this application was November 12, 2025.

Anointed Inspired Remedies Trademark Application

The USPTO has received an intent-to-use trademark application for 'Anointed Inspired Remedies' by a pharmaceutical company. The application covers goods such as herbal teas, medicinal herbal preparations, and castor oil for medical purposes.

USPTO Trademark Publication: Collagen Bio-Peptides Protein

The USPTO has published the trademark application for 'Collagen Bio-Peptides Protein' for nutritional supplements. The application was filed on August 5, 2025, and published for opposition on March 22, 2026.

Green Monkey Trademark Application Published

The USPTO has published the Green Monkey trademark application for herbal supplements for opposition. The application was filed on July 29, 2025, and published on March 22, 2026. This publication initiates a period during which third parties may oppose the trademark registration.

MACRO VITAL USPTO Trademark Application

The USPTO has received an intent-to-use trademark application for the mark 'MACRO VITAL'. The application covers a wide range of dietary and nutritional supplements, including drink mixes, enzyme supplements, protein shakes, and vitamin supplements. The filing date for this application was November 29, 2024.

USPTO Trademark Application: COMPRESSION ASSIST

The United States Patent and Trademark Office (USPTO) has received an intent-to-use trademark application for the mark 'COMPRESSION ASSIST'. The application covers personal lubricants and therapeutic sprays for muscle relaxation. The filing date was November 12, 2024.

USPTO Trademark Application for Pain Management

The USPTO has published a trademark application for "CUSTOM INTERVENTIONAL PAIN MANAGEMENT" for use with local anesthetics and customized medical kits. The application was published for opposition on March 22, 2026, with a filing date of September 24, 2024.

LHOPEBK NATURE Trademark Registration

The USPTO has registered the trademark LHOPEBK NATURE for a variety of dietary supplements, including alginate, casein, enzyme, glucose, lecithin, mineral, pollen, propolis, protein, royal jelly, whey protein, and yeast supplements. The registration was finalized on March 22, 2026, following a filing date of June 11, 2024.

LITIMIC Trademark Status Change

The USPTO has recorded a status change for the LITIMIC trademark application (TM99165165), which covers various pharmaceutical preparations. The status change is noted with an effective date of March 22, 2026.

Hyvia Health Intent to Use Trademark for Herbal Supplements

The USPTO has received an intent-to-use trademark application (TM99100449) from Hyvia Health for herbal supplements. The application covers products intended for longevity, memory, and mental health and clarity.

Centurion Health Trademark Published for Opposition

The United States Patent and Trademark Office (USPTO) has published the trademark application for 'Centurion Health' for opposition. The application covers a range of pharmaceutical products, including allergy medication, cough syrups, dietary supplements, and pain relief medication.

PAWGUS intent to use trademark application filed Mar 22, 2026

PAWGUS intent to use trademark application filed Mar 22, 2026

Micromacros Trademark Publication

The USPTO has published the trademark application for "Micromacros" for nutritional supplements. The application was filed on November 19, 2025, and published for opposition on March 22, 2026. This publication is a procedural step in the trademark registration process.

Prostar Vitamins Trademark Publication

The USPTO has published the Prostar Vitamins trademark application for opposition. The application, filed on November 19, 2025, covers vitamin supplements and was published on March 22, 2026. This publication opens a period for third parties to oppose the trademark registration.

USPTO Trademark Application for CYTOFOOD

The USPTO has received an intent-to-use trademark application (TM99505302) for the mark "CYTOFOOD". The application covers a range of cosmetic products, including anti-aging cleansers, toners, lotions, moisturizers, serums, and facial masks, as well as various dietary and nutritional supplements.

USPTO Trademark Application - Clinical Diagnostic Reagents

The USPTO has received an intent-to-use trademark application (TM99492783) for clinical diagnostic reagents and related medical imaging agents. The application was filed on November 12, 2025, with an effective date of March 22, 2026.

Yellowbird Intent to Use Trademark Application for Diagnostic Reagents

The USPTO has received an intent-to-use trademark application from Yellowbird for diagnostic reagents and radiopharmaceutical agents. The application covers a range of products used in medical imaging, cancer detection, and general diagnostics.

DALICAT Trademark Application Filed

The USPTO has received an intent-to-use trademark application for the mark 'DALICAT'. The application covers a range of pharmaceutical products and supplies for pets, including medicated shampoos, flea and tick treatments, dietary supplements, and dietetic foods for veterinary purposes. The filing date for this application was November 12, 2025.